Neogenomics
NEO
Neogenomics (NEO) news
Recent news
Neogenomics sees FY adj. EBITDA $56M to $58M, saw $55M to $57M
AInvest Wire · Jul 28, 2026Neogenomics sees FY revenue $802M to $806M, saw $797M to $803M
AInvest Wire · Jul 28, 2026Neogenomics Inc: decrease in operating expenses for Q2 2026 was primarily due to $20 mln of impairment charges taken in Q2 2025
AInvest Wire · Jul 28, 2026Neogenomics: expects FY2026 net loss of $42 mln to $34 mln
AInvest Wire · Jul 28, 2026Neogenomics: sees FY2026 adj EBITDA $56 mln to $58 mln
NeoGenomics Inc. (NYSE: NEOG) has provided an updated outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $56 million to $58 million. This guidance reflects the company’s performance and strategic direction as outlined in first-quarter 2026 results . The forecast indicates a…
AInvest Wire · Jul 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.